x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Bayer sues Glenmark over generic Finacea

15-03-2013

Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of rosacea treatment Finacea.


Bayer, Finacea, Intendis, Intraserv, generic, USPTO, patent extension

WIPR

Payment types accepted